Roles of lysophosphatidic acid in cardiovascular physiology and disease
about
Lysophosphatidic acid and apolipoprotein A1 predict increased risk of developing World Trade Center-lung injury: a nested case-control studyBiomarkers of World Trade Center particulate matter exposure: physiology of distal airway and blood biomarkers that predict FEV1 declineIdentification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6Role of oxidized lipids in pulmonary arterial hypertensionRole of platelets in neuroinflammation: a wide-angle perspectiveThe heterotrimeric G protein subunits Gα(q) and Gβ(1) have lysophospholipase D activityLysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3.Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid.Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.LPA induces IL-6 secretion from aortic smooth muscle cells via an LPA1-regulated, PKC-dependent, and p38alpha-mediated pathwayLysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Lysophosphatidic acid induces shear stress-dependent Ca2+ influx in mouse aortic endothelial cells in situ.Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody responseLysophosphatidic acid in atherosclerotic diseasesLysophosphatidic acid level and the incidence of silent brain infarction in patients with nonvalvular atrial fibrillationLysophosphatidic acid increases the electrophysiological instability of adult rabbit ventricular myocardium by augmenting L-type calcium currentLysophosphatidic acid induces integrin activation in vascular smooth muscle and alters arteriolar myogenic vasoconstriction.Spiroguanidine rhodamines as fluorogenic probes for lysophosphatidic acid.Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells.The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA.Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling.Autotaxin overexpression causes embryonic lethality and vascular defectsLysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cellsLysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.Lysophospholipid receptors in vertebrate development, physiology, and pathology.P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion.Structure-based drug design identifies novel LPA3 antagonists.Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase.HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver.Regulation of blood and vascular cell function by bioactive lysophospholipids.Simple enrichment and analysis of plasma lysophosphatidic acids.The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus.Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation.Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.G-protein-mediated signaling in vascular smooth muscle cells - implications for vascular disease.
P2860
Q23915586-274F039A-C2FA-4CFB-9473-5CE4D1A770D1Q23918414-678DCB52-00E2-42D1-B8E7-2BA3C1BF1FA0Q24658261-0424D0F2-607E-4F3E-A7E6-F4329A11AE63Q28078566-42A384B8-A762-47FE-B94C-B08468428F4CQ28393808-62AAB2F7-4D97-4C30-9BAB-6649238ED3F1Q28504918-2767B913-ACF9-4215-B987-5FF861798F5CQ30253010-F4699B65-89B8-4EFD-B17B-92B38090AF30Q33634483-407052A9-0E6C-40E6-8D85-5A283C4CE20FQ33636488-0CF38548-85CB-4FB5-B900-2C980B2B40CFQ33727578-E24191F2-A08B-4A0A-947A-66554BA61F61Q33753311-DF415278-C95A-4866-8EC8-195129B8BA5AQ33825153-C08F63B5-4590-4854-924F-2DCA4FA4355AQ33845710-8B8CBD10-6F1A-4B88-8A43-DF2F634BE479Q34025718-61326D9E-0F53-4C67-876C-77F485BA2695Q34273486-439DEA97-16D8-4420-80A8-9DFCE003E754Q34378059-96BF284E-EE10-4359-850C-BE54628831FCQ34430249-A86AFE53-E668-43DB-BE8D-840015300CCBQ34433358-7241D95B-0DB6-4B40-8B8F-9CE1F63DF672Q35061819-0A147B75-54E2-4CBF-9598-3E42A66ADFBAQ35266443-44E1BC1F-B43D-4DAA-817F-7EB34DFCC497Q35395358-BC08193A-6F68-45AF-8EE3-CFFB17D364FCQ35621592-DBA7DBF4-0A5E-48C7-98D4-E3BCBEB78D5EQ35625325-4E710C84-45A2-45DA-93E0-8C8462CC8D67Q35907288-A22A2515-9D38-4C36-8E93-89A5A710D1B5Q36431033-321B66EC-6E9B-423F-AE48-4FBEEB67680AQ36478250-F712283C-E42A-4C6E-BD3F-417E7CCA216BQ36940630-357AE17E-2C9B-495D-931C-17469A21F718Q37173208-3DAF5B3D-0AAF-416B-A41F-24CB7114CEF3Q37391849-FE05AD78-E61A-4D34-AE54-C36E1C1DD7ECQ37407372-030049BD-8D8F-4FB4-85E7-F502DF3E8068Q37486804-DE04184D-552A-4286-B831-8ABDDE8627C6Q37503698-D9A0824A-6FFF-4CEB-9AA5-C00A69FBD9DAQ37509813-9F083FD2-E18F-4E99-A047-5F5FED7AEE8FQ37561419-D0EB6A4B-5D2E-4B16-8A82-F7BD3AE20100Q37593579-1272B60A-0C43-463F-976C-ACD15DFB9CE0Q37612293-272DE018-E99A-49D8-99B6-307D7A3636DEQ37612339-E649A047-EBB7-4992-BC20-86B46CF0DEE5Q37620329-8EB23F94-759C-43DD-8D77-919B3CCA0A94Q38166800-06B64475-C696-4812-9D6A-F92FF8571EC7Q38526491-2EA0CA28-9C4E-4D11-A63C-BDB637D6B909
P2860
Roles of lysophosphatidic acid in cardiovascular physiology and disease
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Roles of lysophosphatidic acid in cardiovascular physiology and disease
@en
type
label
Roles of lysophosphatidic acid in cardiovascular physiology and disease
@en
prefLabel
Roles of lysophosphatidic acid in cardiovascular physiology and disease
@en
P2093
P2860
P1476
Roles of lysophosphatidic acid in cardiovascular physiology and disease
@en
P2093
Andrew J Morris
Hsin-Yuan Cheng
Sumitra Miriyala
Susan S Smyth
P2860
P304
P356
10.1016/J.BBALIP.2008.05.008
P407
P577
2008-06-10T00:00:00Z